IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v20y2023i4p3039-d1062935.html
   My bibliography  Save this article

Comparison of Short-Term Post-Thymectomy Outcomes by Time-Weighted Dosages of Drug Requirements between Thymoma and Non-Thymoma Myasthenia Gravis Patients

Author

Listed:
  • Phattamon Wiboonpong

    (Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand)

  • Suwanna Setthawatcharawanich

    (Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand)

  • Pat Korathanakhun

    (Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand)

  • Thanyalak Amornpojnimman

    (Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand)

  • Nannapat Pruphetkaew

    (Epidemiology Unit, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand)

  • Pensri Chongphattararot

    (Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand)

  • Chutarat Sathirapanya

    (Department of Family and Preventive Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand)

  • Pornchai Sathirapanya

    (Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand)

Abstract

(1) Background: Early thymectomy is suggested in all clinically indicated myasthenia gravis (MG) patients. However, short-term clinical response after thymectomy in MG patients has been limitedly described in the literature. This study aimed to compare the 5-year post-thymectomy outcomes between thymoma (Th) and non-thymoma (non-Th) MG patients. (2) Methods: MG patients aged ≥18 years who underwent transsternal thymectomy and had tissue histopathology reports in Songklanagarind Hospital between 2002 and 2020 were enrolled in a retrospective review. The differences in the baseline demographics and clinical characteristics between ThMG and non-Th MG patients were studied. We compared the time-weighted averages (TWAs) of daily required dosages of pyridostigmine, prednisolone or azathioprine to efficiently maintain daily living activities and earnings between the MG patient groups during 5 consecutive years following thymectomy. Post-thymectomy clinical status, exacerbations or crises were followed. Descriptive statistics were used for analysis with statistical significance set at p < 0.05. (3) Results: ThMG patients had significantly older ages of onset and shorter times from the MG diagnosis to thymectomy. Male gender was the only significant factor associated with ThMG. TWAs of the daily MG treatment drug dosages required showed no differences between the groups. Additionally, the rates of exacerbations and crises were not different, but decremental trends were shown in both groups after the thymectomies. (4) Conclusions: The daily dosage requirements of MG treatment drugs were not different. There was a trend of decreasing adverse event rates despite no statistically significant differences during the first 5 years after thymectomy in ThMG and non-ThMG patients.

Suggested Citation

  • Phattamon Wiboonpong & Suwanna Setthawatcharawanich & Pat Korathanakhun & Thanyalak Amornpojnimman & Nannapat Pruphetkaew & Pensri Chongphattararot & Chutarat Sathirapanya & Pornchai Sathirapanya, 2023. "Comparison of Short-Term Post-Thymectomy Outcomes by Time-Weighted Dosages of Drug Requirements between Thymoma and Non-Thymoma Myasthenia Gravis Patients," IJERPH, MDPI, vol. 20(4), pages 1-13, February.
  • Handle: RePEc:gam:jijerp:v:20:y:2023:i:4:p:3039-:d:1062935
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/20/4/3039/pdf
    Download Restriction: no

    File URL: https://www.mdpi.com/1660-4601/20/4/3039/
    Download Restriction: no
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:20:y:2023:i:4:p:3039-:d:1062935. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.